Foresite Capital Management VI’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Hold
1,562,500
7.03% 5
2025
Q1
$15.3M Hold
1,562,500
8.35% 4
2024
Q4
$19.8M Buy
+1,562,500
New +$19.8M 8.8% 4